Action of FR901228, a Novel Antitumor Bicyclic Depsipeptide Produced by Chromobacterium violaceum No. 968, on Ha-ras Transformed NIH3T3 Cells.

Bibliographic Information

Other Title
  • Action of FR901228, a Novel Antitumor Bicyclic Depsipeptide Produced by<i>Chromo-bacterium violaceum</i>No. 968, on Ha-<i>ras</i>Transformed NIH3T3 Cells

Search this article

Abstract

FR901228, a novel antitumor antibiotic, reversed the transformed morphology of the Ha-ras transformants, Ras-1 cells, and inhibited their growth. The reduction of c-myc expression was observed in FR901228-treated Ras-1 cells by RNA dot-blot hybridization. This reduction of c-myc expression and morphological reversion of the transformed cells to normal were correlated with growth inhibition (G0/G1 arrest in cell cycle).

Journal

Citations (3)*help

See more

Details 詳細情報について

Report a problem

Back to top